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Introduction 
Central pontine myelinolysis (CPM) is also 
referred to as Osmotic Demyelination Syn-
drome.  It was first identified approximately 
50 years ago. Pontine refers to the stem of 
the brain. Myelin is a covering that protects 
the pontine nerve cells. CPM is a neurological 
disorder defined as a demyelination of the 
nerve cells, in the pontine area and in ex-
treme cases it can extend into the  extra-
pontine area. CPM can occur from various 
reasons, but the most common cause is from 
osmotically induced demyelination, due to 
overly rapid correction of serum sodium in a 
hyponatraemic patient (Medline Plus, 2013). 
Hyponatraemia 
This is a common electrolyte imbalance. 
Sodium is one of the most important         
elements in the body that accounts for 90% of  
extracellular fluid cations. Hyponatraemia 
refers to a sodium deficiency in relation to the  
amount of water in the body (Pradhan, Jha, 
Singh, Gupta, Phadke & Kher,1995).  The 
normal serum level of sodium is 135-
145mmol/L. Common diagnostic tests in pa-
tients with hyponatraemia include:   
x Serum osmolality less than 280mmol/L 
x Serum sodium level less than 135m-
mol/L  
x Urine specific gravity less than 1.010 
Hypernatraemia 
This is a less common problem and refers to 
an excess of sodium relative to the amount of 
water in the body. A patient is considered to 
have hypernatraemia if their serum sodium is 
above 145mmol/L. Sodium balance is main-
tained by Anti Diuretic Hormone (ADH) which 
is secreted from the pituitary gland into the 
blood stream. It can be corrected by lowering 
sodium or increasing body water (Stöppler, 
2013). 
Clinical presentation 
According to the National Institute of Neuro-
logical Disorders and Stroke (2013), the typi-
cal symptoms of CPM usually begin 2-3 days 
after the over-correction of hyponatraemia 
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has occurred. The most commonly ob-
served symptoms of CPM are: 
  - acute quadraparesis 
  - dysphagia 
  - dysarthria 
  - diplopia 
  - loss of consciousness 
The key features of the neurological exam 
include confusion, horizontal gaze paralysis 
and spastic quadriplegia. Increased limb 
tone, weakness, hyperactive reflexes and 
Babinski sign are all typical of lesions involv-
ing upper motor neurons.  
In some instances, brain damage to the 
pons from rapid myelinolysis of the corti-
cobulbar and corticospinal tracts in the 
brainstem leading to “Locked in Syndrome” 
or death. “Locked in Syndrome” is when an 
individual has full consciousness and cogni-
tive function intact, but has severe paralysis 
of the voluntary motor system where move-
ment and communication is not possible, 
however patients are able to blink or move 
their eyes vertically. Delerium and coma are 
extremely common in CPM (Hickey, 2003). 
This results from lesions in the pontine teg-
mentum and/or thalamus.  Magnetic Reso-
nance Imaging (MRI) is the modality of 
choice. MRI images demonstrate hyper-
intense or bright areas where demyelination 
has occurred (Hromanik, 2010).  
Treatment of CPM 
Once demyelination of the pons has started 
there is no cure or very little treatment that 
can be offered (Abbott, Silber, Felber & Ek-
po, 2005). The only treatment is that of the 
symptoms alone.  
These include: 
   - physical therapy, to improve balance and 
retain range of motion in limbs. 
   - a dopagenic medication such as Levodo-
pa to increase dopamine and control trem-
ors and the difficulties with swallowing and 
speech. 
Nurses can assist in the treatment, mainly 
by keeping the patient comfortable. It is im-
perative to source an effective communica-
tion tool, to allow a patient to be involved in 
their care and keep some “normality” in their 
life. Nurses can provide family support and 
refer the patient to the necessary Allied 
Health teams for ongoing management. 
Prognosis 
Although CPM was considered to have the 
mortality rate of 50% or more, early diagno-
sis has led to better prognosis for many. 
Most individuals improve gradually but con-
tinue to live with significant deficits. 
Case Study 
Freddy (not his real name) is a 35 year old 
freelance Graphic Designer and a fitness 
enthusiast. In his spare time he is a fitness 
instructor and ultra-marathon runner.  In 
2011 Freddy went to Morocco to compete in 
the Marathon des Sables or the Marathon of 
the Sands which is a 6 day stage race which 
covers 250 km through the Sahara Desert. 
This multiday event is held every year and is 
considered the toughest foot race on Earth.  
On day 3 of the event Freddy was acting 
normally and interacting with friends. Late in 
the evening Freddy was found near his tent 
suffering leg cramps, he was confused and 
it was evident that he had been vomiting. He 
was assessed by race doctors and given 
fluids, and it was recommended that he be 
transferred to the closest major hospital.   
Whilst travelling to the base camp the next 
day Freddy had a single convulsive episode, 
and became more confused and agitated.  
Subsequently he was rushed by ambulance 
to a major hospital in Egypt.  On arrival to 
the hospital it was reported that two other 
athletes were admitted to the same hospital 
with similar conditions. Freddy was admitted 
on 8th October 2011, his blood profile was: 
x Serum NaΆ was 108mmol/L 
x Rest of electrolytes were normal 
x Creatinine Kinase (CK) was 30,000u/
L(<1,000u/L) 
Elevated levels of the enzyme CK indicate 
muscle damage or muscle strain such as in 
the case of a heart attack or the muscles 
being overworked (Medical Health Tests, 
2011). In this case the excessive running in 
the marathon done by Freddy could have 
contributed to his high CK levels. 
Freddy’s vital signs were as follows BP 
125/53, HR 92bpm, RR 25bpm, central tem-
perature was 42.9Ԩ, and Sp02 99% on RA. 
His GCS was 13 (E4 V4 M5). 
There was nothing obvious reported on both 
his CT and MRI.  It was decided that treat-
ment would start focusing on, the correction 
of electrolyte imbalance, treatment of rhab-
domyolysis, the management of disturbed 
level of consciousness, and the treatment of 
fever.  It was recommended that Freddy 
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stay in the ICU for closer monitoring. 
An unknown IVF was infused at 200ml/hr and 
hypertonic saline was given at a rate of 20ml/
hr to correct symptomatic hyponatraemia. 
Freddy was administered antipyretics to con-
trol fever and he was also started on antimi-
crobial and anti-viral medication to control 
possible infection, as well as anticonvulsants 
for his reported seizures. 
On 9th October 2011, approximately around 
36 hours after treatment had started it was 
documented that Freddy’s CK levels had sig-
nificantly declined but were still slightly ele-
vated and his Na+ levels had started to rise 
‘gradually’ reaching 138mmol/L. However 
Freddy’s LOC did not improve, the medical 
staff mentioned he had become ‘locked in’, 
with no eye fixation, increased motor tone 
and spasticity, and an inability to walk or sit 
independently. He also had 2 or 3 general-
ised seizures around this time.  The team 
decided that if Freddy’s LOC didn’t improve 
in the next few days they would do a spinal 
tap/lumbar puncture.  
A MRI of the brain (Figure 1) was performed 
to exclude central causes, but showed that 
no abnormalities were detected.  On October 
10th 2011, Freddy’s vital signs were - BP 
110/50, HR 89bpm, RR 21bpm, Sp02 99% 
on RA, temperature 38.2°C, and urine output 
200mls/hr. 
It was documented that Freddy’s current di-
agnosis was symptomatic hyponatraemia, 
heat stroke, and rhabdomyolysis. The team 
were unsure of what was happening to Fred-
dy, a reporting medical officer said... “I can-
not explain his elevated enzymes...and alt-
hough they have dropped, they still remain in 
the thousands.....I am unclear of what is go-
ing on. The low Na+ and the dehydration 
have been corrected, and there is nothing 
obvious in the brain neither on his CT or MRI. 
There are no signs of infection, his breathing 
is normal, his chest is clear, and his abdo-
men is soft.....I am treating him conservative-
ly without any specific diagnosis at hand.” 
The medical staff decided that Freddy had 
treatment to the level of care able to be pro-
vided and that it would be beneficial for him 
to travel to a higher level of care for re-
evaluation and second opinion. A German 
hospital answered the call and agreed to ac-
cept Freddy under their care. 
Freddy arrived in Germany 12th October 
2011, ninety-six hours after initial onset. Pri-
mary reports state that “the patient is awake 
but unresponsive with present mutism, the 
general muscle tone of his extremities and 
torso are increased, his neural tension tests 
were positive, and he showed negative Ba-
binski signs bilaterally.” 
Initial MRI showed abnormalities in the left 
corpus callosum, para-hippocampal gyrus 
and left occipital lobe, his EEG was abnormal 
and suggestive of subcortical dysfunction, 
without potentials for epilepsy, and CSF re-
sults from spinal tap/lumbar puncture showed 
only a minor disturbance of the barrier func-
tion, and no indications for an inflammatory 
infection of the CNS.  Given these results 
and the patient history the medical staff in 
Germany decided to initiate anti-epileptic 
therapy in the form of Levetiracetam. Freddy 
tolerated this and the dose was gradually 
increased to 2000mg daily with no further 
seizures occurring. Freddy was also pre-
scribed a dopagenic medication to help facili-
tate activation of his muscles, and a muscle 
relaxant to reduce his increased limb tone. 
After thirty-six hours, Freddy’s limb tone de-
creased with right sided emphasis, and there 
was a positive right-sided Babinski sign. With 
these medications and intensive physio and 
occupational therapy Freddy progressively 
began to communicate more and became 
more aware of his surroundings. He also be-
gan tracking and his eyes started to fixate on 
persons speaking when he was addressed. 
Although Freddy was becoming more re-
sponsive, he still suffered from mutism or 
being ‘locked in’. This proved difficult for 
Figure 1 (Above): Freddy’s MRI on presentation at 
Westmead Hospital. 
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communication. Also difficult was swallowing 
and due to his dysphagia, a PEG tube was 
inserted without complications, to help with 
nutritional support. 
A repeat MRI was attended and showed gen-
eralised changes consistent with metabolic or 
hypoxic brain injury. However the team rec-
orded that ‘the reason for the patient’s actual 
status could not be clarified at this time.’ It 
was decided that Freddy’s ‘brain damage’ is 
likely due to him suffering from major fluctua-
tions of electrolyte balance at an early stage, 
where his severe hyponatraemia was 
promptly corrected. It was decided that Fred-
dy would require long term neurological reha-
bilitation, preferably in his home country Aus-
tralia. This could be done immediately as 
Freddy was safe to fly on a commercial flight 
as long as he had a medical escort with him.  
Freddy arrived at Westmead Hospital in Aus-
tralia 1st November, 2011. The medical 
teams’ initial plan for Freddy on admission 
was for a physiotherapy and occupational 
therapy assessment, a speech pathology 
assessment re: speech and diet, rehabilita-
tion referral, social worker review, and dieti-
tian review. 
Initial assessments included- 
x Physiotherapy (PT): 
 Freddy refused to cooperate and 
wanted to return to bed to sleep 
 Able to stand and walk          
independently Freddy was not 
compliant with the PT staff. 
 Freddy showed no strength   
deficits 
 Throughout the exchange he 
was unable to communicate  
verbally and showed incon-
sistent eye contact. 
x Dietitian: 
 Commence on bolus feeds 
through the PEG tube 
 6 times a day with 4 hourly     
water flushes of 150ml. 
x Speech Pathology (SP): 
 Communication: Auditory com-
prehension - Freddy was not 
following commands, not        
responding to yes/no questions, 
and not looking at objects.                         
Verbal expression- Freddy was 
only making minimal eye      
contact. He had no facial       
expressions, made no gestures 
and gave no verbal output. 
 Functional impression: Patient 
presents with significant        
cognitive impairment, including 
severe communication impair-
ment.  He is unable to under-
stand simple commands. 
 It was documented Freddy    
suffered from severe global 
aphasia, and would benefit from 
intensive communication       
rehabilitation.      
x Occupational Therapy (OT): 
 Freddy has non-purposeful   
upper limb active movement. 
 He reaches out, grasps, seeks 
stimuli but not to command. 
 Patient inconsistently fixing on 
OT’s initial entry to room and he 
is fixed on the OT’s face mimick-
ing their gestures eg: smile. 
x Social Work (SW): 
 Noticed the family had been 
through a ‘roller coaster ride’ of 
emotions to which the SW pro-
vided supportive counselling and 
education. 
 Freddy’s mum is the primary 
carer for her husband and has 
applied to be Freddy’s carer. 
It was confirmed by the neurology team 2nd 
November 2011, that Freddy’s condition was 
due to the rapid correction of hyponatraemia 
hence giving the diagnosis of central pontine 
myelinolysis. Despite the new diagnosis, 
Freddy continued to improve.  Within 1 week 
of arriving at Westmead he was making eye 
contact and smiling at the staff, mobilising up 
to 300m independently only requiring direc-
tional assistance, tolerating an oral puree diet 
with pudding and thickened fluids, attempting 
some yes/no responses, and speaking in 
jumbled sentences with some coherent 
words. 
Freddy was seen by the Rehabilitation Team 
as a 2 week trial to see if he would be suita-
ble for rehabilitation in the Brain Injury Unit 
(BIU).  Initially Freddy was unable to com-
plete simple tasks such as combing his hair. 
It was noted whenever Freddy became tired 
he became increasingly agitated.  So it was 
decided short sessions would be most bene-
ficial for Freddy. At the end of the 2 week 
rehabilitation trial Freddy significantly im-
proved cognitively.  After 10 weeks and 3 
hospitals, it was decided that Freddy would 
be transferred to the BIU 14th December 
2011, to continue his extensive rehabilitation. 
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Freddy spent 16 weeks in the BIU at West-
mead Hospital he was discharged home un-
der the care of his parents 5th April 2012, af-
ter several successful home trials. On dis-
charge Freddy was able to reliably indicate 
yes/no using a non-verbal thumbs up or 
down in response to direct questions, use an 
increased portion of real and non-real words, 
and he was able to understand and follow 
simple routine spoken commands such as ‘sit 
down’.  Freddy was able to use some routine 
gestures in a functional manner such as 
pointing to a comb and gesturing brushing his 
hair, understand the spoken function of most 
daily objects, reliably follow conversations 
with staff and family, demonstrate active lis-
tening skills such as looking at the other per-
son, nodding his head and using fillers such 
as ‘yeah’ or ‘okay’. 
Conclusion 
Freddy now lives at home with his parents 
who are his guardians. Although he will never 
be able to live independently by himself re-
ports from his family are that his sense of 
humour remains the same, as he constantly 
is playing tricks on his family which he finds 
amusing. He does have good and bad days 
but his family report that he is a pleasure to 
be around and most pleasing of all for Freddy 
is that he has joined a running club which he 
attends three times a week which he is en-
joys immensely.   
From the case study and the demonstrated 
evidence, it is clear that patients presenting 
with hyponatraemia should be closely moni-
tored whilst sodium correction is taking place. 
CPM symptoms can mask other neurological 
conditions so it is imperative that the ‘over 
correction’ of sodium does not take place, 
and that the replacement of sodium does not 
exceed 8-10mmol/l in a 24 hour period, which 
is the recommended rate of replacement. It is 
also advised to consider CPM as a diagnosis 
when patients display signs and symptoms, 
such as diplopia and a decreased level of 
consciousness. This early detection can en-
sure that the patient receives adequate treat-
ment and that appropriate rehabilitation can 
take place.   
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